Pharmacists and Diabetes Management
Published Online: Thursday, November 21, 2013
In this video, Jonathan G. Marquess, PharmD, CDE, President and CEO of the Institute for Wellness and Education, Inc, discusses the role that pharmacists can play in helping patients improve management of their diabetes. This video was shot at the National Community Pharmacists Association 115th Annual Convention in Orlando.
The FDA has approved the intravitreal implant, Iluvien 0.19 mg, as the first long-term treatment for diabetic macular edema.
Pharmacists who participate in community-based diabetes care teams play a pivotal role in reducing A1C levels among patients with poorly controlled diabetes.
The dexamethasone intravitreal implant, Ozurdex, is now indicated to treat all patients with diabetic macular edema.